查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530931

荷尔蒙替代疗法市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Hormone Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 164 Pages | 商品交期: 2-10个工作天内

价格

荷尔蒙替代疗法市场 - 报告范围

TMR 关于全球荷尔蒙替代疗法市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。期间的市场，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球荷尔蒙替代疗法市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解荷尔蒙替代疗法市场。

市场概况
2023年市场价值 210 亿美元
2034 年市场价值 388 亿美元
复合年增长率 5.7%

该报告深入研究了全球荷尔蒙替代疗法市场的竞争格局。全球荷尔蒙替代疗法市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球荷尔蒙替代疗法市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依治疗类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依治疗类型，2020-2034
    • 人类生长激素 (HGH) 替代疗法
    • 甲状腺替代疗法
    • 睾酮替代疗法
    • 多巴胺激动剂
    • 生长抑素类似物
    • 其他（副甲状腺等）
  • 市场吸引力：按治疗类型

第 7 章：全球市场分析与预测：按管理途径

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依给药途径，2020-2034年
    • 口服
    • 注射用
    • 透皮
  • 市场吸引力：依给药途径分类

第 8 章：全球市场分析与预测：按疾病适应症

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依疾病适应症，2020-2034
    • 停经
    • 甲状腺功能低下症
    • 男性性腺功能减退症
    • 生长激素缺乏
    • 副甲状腺功能减退症
  • 市场吸引力：依疾病适应症分类

第 9 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020-2034
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力：按配销通路划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Novartis AG
    • Abbott Laboratories
    • Mylan NV
    • Merck & Co., Inc.
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals Co.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Eli, Lilly and Company
    • AbbVie Inc.
    • Noven Pharmaceuticals
Product Code: TMRGL610

Hormone Replacement Therapy Market - Scope of Report

TMR's report on the global hormone replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hormone replacement therapy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormone replacement therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hormone replacement therapy market.

Market Snapshot
Market Value in 2023US$ 21 Bn
Market Value in 2034US$ 38.8 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormone replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormone replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormone replacement therapy market.

The report delves into the competitive landscape of the global hormone replacement therapy market. Key players operating in the global hormone replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormone replacement therapy market profiled in this report.

Key Questions Answered in Global hormone replacement therapy Market Report:

  • What is the sales/revenue generated by hormone replacement therapy across all regions during the forecast period?
  • What are the opportunities in the global hormone replacement therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hormone Replacement Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global hormone replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormone replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormone replacement therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hormone Replacement Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Hormone Replacement Therapy Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Hormone Replacement Therapy Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2020-2034
    • 6.3.1. Human Growth Hormone (HGH) Replacement Therapy
    • 6.3.2. Thyroid Replacement Therapy
    • 6.3.3. Testosterone Replacement Therapy
    • 6.3.4. Dopamine Agonist
    • 6.3.5. Somatostatin Analogue
    • 6.3.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 6.4. Market Attractiveness, by Treatment Type

7. Global Hormone Replacement Therapy Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Transdermal
  • 7.4. Market Attractiveness, by Route of Administration

8. Global Hormone Replacement Therapy Market Analysis and Forecast, by Disease Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Indication, 2020-2034
    • 8.3.1. Menopause
    • 8.3.2. Hypothyroidism
    • 8.3.3. Male Hypogonadism
    • 8.3.4. Growth Hormone Deficiency
    • 8.3.5. Hypoparathyroidism
  • 8.4. Market Attractiveness, by Disease Indication

9. Global Hormone Replacement Therapy Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness, by Distribution Channel

10. Global Hormone Replacement Therapy Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Hormone Replacement Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 11.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 11.2.2. Thyroid Replacement Therapy
    • 11.2.3. Testosterone Replacement Therapy
    • 11.2.4. Dopamine Agonist
    • 11.2.5. Somatostatin Analogue
    • 11.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 11.3. Market Attractiveness, by Treatment Type
  • 11.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Transdermal
  • 11.5. Market Attractiveness, by Route of Administration
  • 11.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 11.6.1. Menopause
    • 11.6.2. Hypothyroidism
    • 11.6.3. Male Hypogonadism
    • 11.6.4. Growth Hormone Deficiency
    • 11.6.5. Hypoparathyroidism
  • 11.7. Market Attractiveness, by Disease Indication
  • 11.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.8.1. Hospital Pharmacies
    • 11.8.2. Retail Pharmacies
    • 11.8.3. Online Pharmacies
  • 11.9. Market Attractiveness, by Distribution Channel
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Treatment Type
    • 11.11.2. By Route of Administration
    • 11.11.3. By Disease Indication
    • 11.11.4. By Distribution Channel
    • 11.11.5. By Country

12. Europe Hormone Replacement Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 12.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 12.2.2. Thyroid Replacement Therapy
    • 12.2.3. Testosterone Replacement Therapy
    • 12.2.4. Dopamine Agonist
    • 12.2.5. Somatostatin Analogue
    • 12.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 12.3. Market Attractiveness, by Treatment Type
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Transdermal
  • 12.5. Market Attractiveness, by Route of Administration
  • 12.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 12.6.1. Menopause
    • 12.6.2. Hypothyroidism
    • 12.6.3. Male Hypogonadism
    • 12.6.4. Growth Hormone Deficiency
    • 12.6.5. Hypoparathyroidism
  • 12.7. Market Attractiveness, by Disease Indication
  • 12.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.8.1. Hospital Pharmacies
    • 12.8.2. Retail Pharmacies
    • 12.8.3. Online Pharmacies
  • 12.9. Market Attractiveness, by Distribution Channel
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Treatment Type
    • 12.11.2. By Route of Administration
    • 12.11.3. By Disease Indication
    • 12.11.4. By Distribution Channel
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Hormone Replacement Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 13.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 13.2.2. Thyroid Replacement Therapy
    • 13.2.3. Testosterone Replacement Therapy
    • 13.2.4. Dopamine Agonist
    • 13.2.5. Somatostatin Analogue
    • 13.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 13.3. Market Attractiveness, by Treatment Type
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Transdermal
  • 13.5. Market Attractiveness, by Route of Administration
  • 13.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 13.6.1. Menopause
    • 13.6.2. Hypothyroidism
    • 13.6.3. Male Hypogonadism
    • 13.6.4. Growth Hormone Deficiency
    • 13.6.5. Hypoparathyroidism
  • 13.7. Market Attractiveness, by Disease Indication
  • 13.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.8.1. Hospital Pharmacies
    • 13.8.2. Retail Pharmacies
    • 13.8.3. Online Pharmacies
  • 13.9. Market Attractiveness, by Distribution Channel
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Treatment Type
    • 13.11.2. By Route of Administration
    • 13.11.3. By Disease Indication
    • 13.11.4. By Distribution Channel
    • 13.11.5. By Country/Sub-region

14. Latin America Hormone Replacement Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 14.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 14.2.2. Thyroid Replacement Therapy
    • 14.2.3. Testosterone Replacement Therapy
    • 14.2.4. Dopamine Agonist
    • 14.2.5. Somatostatin Analogue
    • 14.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 14.3. Market Attractiveness, by Treatment Type
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Transdermal
  • 14.5. Market Attractiveness, by Route of Administration
  • 14.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 14.6.1. Menopause
    • 14.6.2. Hypothyroidism
    • 14.6.3. Male Hypogonadism
    • 14.6.4. Growth Hormone Deficiency
    • 14.6.5. Hypoparathyroidism
  • 14.7. Market Attractiveness, by Disease Indication
  • 14.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.8.1. Hospital Pharmacies
    • 14.8.2. Retail Pharmacies
    • 14.8.3. Online Pharmacies
  • 14.9. Market Attractiveness, by Distribution Channel
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Treatment Type
    • 14.11.2. By Route of Administration
    • 14.11.3. By Disease Indication
    • 14.11.4. By Distribution Channel
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Hormone Replacement Therapy Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 15.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 15.2.2. Thyroid Replacement Therapy
    • 15.2.3. Testosterone Replacement Therapy
    • 15.2.4. Dopamine Agonist
    • 15.2.5. Somatostatin Analogue
    • 15.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 15.3. Market Attractiveness, by Treatment Type
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Transdermal
  • 15.5. Market Attractiveness, by Route of Administration
  • 15.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 15.6.1. Menopause
    • 15.6.2. Hypothyroidism
    • 15.6.3. Male Hypogonadism
    • 15.6.4. Growth Hormone Deficiency
    • 15.6.5. Hypoparathyroidism
  • 15.7. Market Attractiveness, by Disease Indication
  • 15.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.8.1. Hospital Pharmacies
    • 15.8.2. Retail Pharmacies
    • 15.8.3. Online Pharmacies
  • 15.9. Market Attractiveness, by Distribution Channel
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Treatment Type
    • 15.11.2. By Route of Administration
    • 15.11.3. By Disease Indication
    • 15.11.4. By Distribution Channel
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Novartis AG
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Abbott Laboratories
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Mylan N.V.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck & Co., Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Bayer AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Pfizer Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Novo Nordisk A/S
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. QuatRx Pharmaceuticals Co.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Amgen Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Eli, Lilly and Company
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. AbbVie Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Noven Pharmaceuticals
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 02: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 03: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 05: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 08: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 09: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 10: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 13: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 14: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 15: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 18: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 19: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 20: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 23: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 24: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 25: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 28: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 29: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 30: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Hormone Replacement Therapy Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Treatment Type, 2023
  • Figure 03: Global Hormone Replacement Therapy Market Value Share, by Treatment Type, 2023
  • Figure 04: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Route of Administration, 2023
  • Figure 05: Global Hormone Replacement Therapy Market Value Share, by Route of Administration, 2023
  • Figure 06: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Disease Indication, 2023
  • Figure 07: Global Hormone Replacement Therapy Market Value Share, by Disease Indication, 2023
  • Figure 08: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 09: Global Hormone Replacement Therapy Market Value Share, by Distribution Channel, 2023
  • Figure 10: Global Hormone Replacement Therapy Market Value Share, by Region, 2023
  • Figure 11: Global Hormone Replacement Therapy Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 13: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 14: Global Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 15: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 16: Global Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 17: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 18: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 19: Global Hormone Replacement Therapy Market Value Share, by Distribution Channel, 2023
  • Figure 20: Global Hormone Replacement Therapy Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Hormone Replacement Therapy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 26: North America Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 27: North America Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 28: North America Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 29: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 30: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 31: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 32: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 33: Europe Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 37: Europe Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 38: Europe Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 39: Europe Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 40: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 41: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 42: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 43: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 44: Asia Pacific Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 48: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 49: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 50: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 51: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 52: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 53: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 54: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 55: Latin America Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 59: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 60: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 61: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 62: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 63: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 64: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 65: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 66: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 70: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 71: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 72: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 74: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 75: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 76: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034